Detalhe da pesquisa
1.
Contributions of amyloid beta and cerebral small vessel disease in clinical decline.
Alzheimers Dement;
20(3): 1868-1880, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38146222
2.
Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer's disease CSF profile of neuronal injury and inflammation.
Mol Psychiatry;
27(4): 1990-1999, 2022 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35173266
3.
Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traits.
Alzheimers Dement;
19(6): 2317-2331, 2023 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36464806
4.
Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiology.
Alzheimers Dement;
2022 Jun 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35698882
5.
Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe.
Alzheimers Dement;
18(1): 29-42, 2022 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33984176
6.
Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics.
Brain;
143(12): 3776-3792, 2020 12 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33439986
7.
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels.
Alzheimers Dement;
17(10): 1628-1640, 2021 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33991015
8.
Replication study of plasma proteins relating to Alzheimer's pathology.
Alzheimers Dement;
17(9): 1452-1464, 2021 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33792144
9.
Vascular risk factors are associated with longitudinal changes in cerebrospinal fluid tau markers and cognition in preclinical Alzheimer's disease.
Alzheimers Dement;
15(9): 1149-1159, 2019 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31378575
10.
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype.
Alzheimers Dement;
15(7): 888-898, 2019 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31164314
11.
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum.
Alzheimers Dement;
15(5): 644-654, 2019 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30853464
12.
Inflammatory biomarkers in Alzheimer's disease plasma.
Alzheimers Dement;
15(6): 776-787, 2019 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31047856
13.
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort.
Alzheimers Dement;
15(6): 817-827, 2019 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31078433
14.
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay.
Alzheimers Dement;
15(11): 1478-1488, 2019 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31495601
15.
Healthcare utilization patterns of individuals with depression after national policy to increase the mental health workforce in primary care: a data linkage study.
BMC Prim Care;
25(1): 158, 2024 May 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38720260
16.
Healthcare utilization patterns for knee and hip osteoarthritis before and after changes in national health insurance coverage: a data linkage study from the Netherlands.
Health Policy;
133: 104825, 2023 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37172521
17.
Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioning.
Genome Med;
15(1): 79, 2023 10 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37794492
18.
Detection of primary Sjögren's syndrome in primary care: developing a classification model with the use of routine healthcare data and machine learning.
BMC Prim Care;
23(1): 199, 2022 08 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35945489
19.
Effects of age, amyloid, sex, and APOE ε4 on the CSF proteome in normal cognition.
Alzheimers Dement (Amst);
14(1): e12286, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35571963
20.
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease.
Mol Neurodegener;
17(1): 27, 2022 03 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35346299